Strata Critical Medical, Inc. (SRTA)
NASDAQ: SRTA · Real-Time Price · USD
5.72
-0.16 (-2.72%)
At close: Jan 8, 2026, 4:00 PM EST
5.83
+0.11 (1.92%)
After-hours: Jan 8, 2026, 7:43 PM EST
Strata Critical Medical Market Cap
Strata Critical Medical has a market cap or net worth of $494.02 million as of January 8, 2026. Its market cap has increased by 60.92% in one year.
Market Cap
494.02M
Enterprise Value
421.57M
1-Year Change
60.92%
Ranking
Category
Stock Price
$5.72
Market Cap Chart
Since November 5, 2019, Strata Critical Medical's market cap has increased from $335.16M to $494.02M, an increase of 47.40%. That is a compound annual growth rate of 6.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 507.84M | 22.25% |
| Dec 31, 2025 | 415.42M | 24.81% |
| Dec 31, 2024 | 332.83M | 26.33% |
| Dec 29, 2023 | 263.46M | 2.70% |
| Dec 30, 2022 | 256.52M | -58.82% |
| Dec 31, 2021 | 622.98M | 63.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.55B |
| Johnson & Johnson | 492.24B |
| AbbVie | 389.14B |
| UnitedHealth Group | 309.81B |
| AstraZeneca | 280.48B |
| Merck & Co. | 266.67B |
| Novartis AG | 262.61B |
| Novo Nordisk | 241.55B |